title: The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution?
authors.forename: Costi
authors.initials: C
authors.lastname: Alifrangis
authors.forename: Jonathan
authors.initials: J
authors.lastname: Krell
authors.forename: Justin
authors.initials: J
authors.lastname: Stebbing
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000639:trends; D017850:Economics, Pharmaceutical; D005062:European Union; D015276:Health Care Rationing; D006801:Humans; D054524:Medicare Part D; D018803:Models, Economic; D009369:Neoplasms / Q000188:drug therapy*; D014481:United States